世界のエピジェネティクス医薬品＆診断技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epigenetics Drugs & Diagnostic Technologies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4198 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、エピジェネティクス医薬品＆診断技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エピジェネティクス医薬品、エピジェネティクス診断技術）、用途別市場規模（病院、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エピジェネティクス医薬品＆診断技術の市場動向 ・企業の競争状況、市場シェア ・エピジェネティクス医薬品＆診断技術の種類別市場規模と予測2016-2027（エピジェネティクス医薬品、エピジェネティクス診断技術） ・エピジェネティクス医薬品＆診断技術の用途別市場規模と予測2016-2027（病院、研究機関、その他） ・エピジェネティクス医薬品＆診断技術の北米市場規模2016-2027（アメリカ、カナダ） ・エピジェネティクス医薬品＆診断技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エピジェネティクス医薬品＆診断技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エピジェネティクス医薬品＆診断技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・エピジェネティクス医薬品＆診断技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（4SC、Acetylon Pharmaceuticals、Astex Pharmaceuticals、CellCentric、Celleron Therapeutics、Celgene Corporation、Chroma Therapeutics、Epigentek Group、Eisai、EnVivo Pharmaceuticals、Base Genomics、Oryzon Genomics） ・結論

Market Analysis and Insights: Global Epigenetics Drugs & Diagnostic Technologies Market
The global Epigenetics Drugs & Diagnostic Technologies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epigenetics Drugs & Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epigenetics Drugs & Diagnostic Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epigenetics Drugs & Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epigenetics Drugs & Diagnostic Technologies market.

Global Epigenetics Drugs & Diagnostic Technologies Scope and Market Size
Epigenetics Drugs & Diagnostic Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetics Drugs & Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Epigenetics Drugs
Epigenetics Diagnostic Technologies

Segment by Application
Hospital
Research Institution
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
4SC
Acetylon Pharmaceuticals
Astex Pharmaceuticals
CellCentric
Celleron Therapeutics
Celgene Corporation
Chroma Therapeutics
Epigentek Group
Eisai
EnVivo Pharmaceuticals
Base Genomics
Oryzon Genomics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Epigenetics Drugs
1.2.3 Epigenetics Diagnostic Technologies
1.3 Market by Application
1.3.1 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Perspective (2016-2027)
2.2 Epigenetics Drugs & Diagnostic Technologies Growth Trends by Regions
2.2.1 Epigenetics Drugs & Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epigenetics Drugs & Diagnostic Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2022-2027)
2.3 Epigenetics Drugs & Diagnostic Technologies Industry Dynamic
2.3.1 Epigenetics Drugs & Diagnostic Technologies Market Trends
2.3.2 Epigenetics Drugs & Diagnostic Technologies Market Drivers
2.3.3 Epigenetics Drugs & Diagnostic Technologies Market Challenges
2.3.4 Epigenetics Drugs & Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue
3.1.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue (2016-2021)
3.1.2 Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Drugs & Diagnostic Technologies Revenue
3.4 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs & Diagnostic Technologies Revenue in 2020
3.5 Epigenetics Drugs & Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Type
4.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Type (2016-2021)
4.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2022-2027)

5 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Application
5.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Application (2016-2021)
5.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027)
6.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type
6.2.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021)
6.2.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027)
6.2.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027)
6.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application
6.3.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021)
6.3.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027)
6.3.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027)
6.4 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country
6.4.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021)
6.4.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027)
7.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type
7.2.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021)
7.2.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027)
7.2.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027)
7.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application
7.3.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021)
7.3.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027)
7.3.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027)
7.4 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country
7.4.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021)
7.4.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027)
8.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type
8.2.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application
8.3.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region
8.4.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027)
9.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type
9.2.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027)
9.2.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027)
9.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application
9.3.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027)
9.3.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027)
9.4 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country
9.4.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027)
10.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type
10.2.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application
10.3.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country
10.4.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 4SC
11.1.1 4SC Company Details
11.1.2 4SC Business Overview
11.1.3 4SC Epigenetics Drugs & Diagnostic Technologies Introduction
11.1.4 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.1.5 4SC Recent Development
11.2 Acetylon Pharmaceuticals
11.2.1 Acetylon Pharmaceuticals Company Details
11.2.2 Acetylon Pharmaceuticals Business Overview
11.2.3 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.2.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.2.5 Acetylon Pharmaceuticals Recent Development
11.3 Astex Pharmaceuticals
11.3.1 Astex Pharmaceuticals Company Details
11.3.2 Astex Pharmaceuticals Business Overview
11.3.3 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.3.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.3.5 Astex Pharmaceuticals Recent Development
11.4 CellCentric
11.4.1 CellCentric Company Details
11.4.2 CellCentric Business Overview
11.4.3 CellCentric Epigenetics Drugs & Diagnostic Technologies Introduction
11.4.4 CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.4.5 CellCentric Recent Development
11.5 Celleron Therapeutics
11.5.1 Celleron Therapeutics Company Details
11.5.2 Celleron Therapeutics Business Overview
11.5.3 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.5.4 Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.5.5 Celleron Therapeutics Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Introduction
11.6.4 Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.6.5 Celgene Corporation Recent Development
11.7 Chroma Therapeutics
11.7.1 Chroma Therapeutics Company Details
11.7.2 Chroma Therapeutics Business Overview
11.7.3 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.7.4 Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.7.5 Chroma Therapeutics Recent Development
11.8 Epigentek Group
11.8.1 Epigentek Group Company Details
11.8.2 Epigentek Group Business Overview
11.8.3 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Introduction
11.8.4 Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.8.5 Epigentek Group Recent Development
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Eisai Business Overview
11.9.3 Eisai Epigenetics Drugs & Diagnostic Technologies Introduction
11.9.4 Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.9.5 Eisai Recent Development
11.10 EnVivo Pharmaceuticals
11.10.1 EnVivo Pharmaceuticals Company Details
11.10.2 EnVivo Pharmaceuticals Business Overview
11.10.3 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.10.4 EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.10.5 EnVivo Pharmaceuticals Recent Development
11.11 Base Genomics
11.11.1 Base Genomics Company Details
11.11.2 Base Genomics Business Overview
11.11.3 Base Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
11.11.4 Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.11.5 Base Genomics Recent Development
11.12 Oryzon Genomics
11.12.1 Oryzon Genomics Company Details
11.12.2 Oryzon Genomics Business Overview
11.12.3 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
11.12.4 Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
11.12.5 Oryzon Genomics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Epigenetics Drugs
Table 3. Key Players of Epigenetics Diagnostic Technologies
Table 4. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2016-2021)
Table 8. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2022-2027)
Table 10. Epigenetics Drugs & Diagnostic Technologies Market Trends
Table 11. Epigenetics Drugs & Diagnostic Technologies Market Drivers
Table 12. Epigenetics Drugs & Diagnostic Technologies Market Challenges
Table 13. Epigenetics Drugs & Diagnostic Technologies Market Restraints
Table 14. Global Epigenetics Drugs & Diagnostic Technologies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players (2016-2021)
Table 16. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2020)
Table 17. Ranking of Global Top Epigenetics Drugs & Diagnostic Technologies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
Table 21. Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Table 25. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Epigenetics Drugs & Diagnostic Technologies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2016-2021)
Table 29. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 61. 4SC Company Details
Table 62. 4SC Business Overview
Table 63. 4SC Epigenetics Drugs & Diagnostic Technologies Product
Table 64. 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 65. 4SC Recent Development
Table 66. Acetylon Pharmaceuticals Company Details
Table 67. Acetylon Pharmaceuticals Business Overview
Table 68. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 69. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 70. Acetylon Pharmaceuticals Recent Development
Table 71. Astex Pharmaceuticals Company Details
Table 72. Astex Pharmaceuticals Business Overview
Table 73. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 74. Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 75. Astex Pharmaceuticals Recent Development
Table 76. CellCentric Company Details
Table 77. CellCentric Business Overview
Table 78. CellCentric Epigenetics Drugs & Diagnostic Technologies Product
Table 79. CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 80. CellCentric Recent Development
Table 81. Celleron Therapeutics Company Details
Table 82. Celleron Therapeutics Business Overview
Table 83. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Product
Table 84. Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 85. Celleron Therapeutics Recent Development
Table 86. Celgene Corporation Company Details
Table 87. Celgene Corporation Business Overview
Table 88. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Product
Table 89. Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 90. Celgene Corporation Recent Development
Table 91. Chroma Therapeutics Company Details
Table 92. Chroma Therapeutics Business Overview
Table 93. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Product
Table 94. Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 95. Chroma Therapeutics Recent Development
Table 96. Epigentek Group Company Details
Table 97. Epigentek Group Business Overview
Table 98. Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 99. Epigentek Group Recent Development
Table 100. Eisai Company Details
Table 101. Eisai Business Overview
Table 102. Eisai Epigenetics Drugs & Diagnostic Technologies Product
Table 103. Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 104. Eisai Recent Development
Table 105. EnVivo Pharmaceuticals Company Details
Table 106. EnVivo Pharmaceuticals Business Overview
Table 107. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product
Table 108. EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 109. EnVivo Pharmaceuticals Recent Development
Table 110. Base Genomics Company Details
Table 111. Base Genomics Business Overview
Table 112. Base Genomics Epigenetics Drugs & Diagnostic Technologies Product
Table 113. Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 114. Base Genomics Recent Development
Table 115. Oryzon Genomics Company Details
Table 116. Oryzon Genomics Business Overview
Table 117. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Product
Table 118. Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 119. Oryzon Genomics Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Type: 2020 VS 2027
Figure 2. Epigenetics Drugs Features
Figure 3. Epigenetics Diagnostic Technologies Features
Figure 4. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Research Institution Case Studies
Figure 7. Others Case Studies
Figure 8. Epigenetics Drugs & Diagnostic Technologies Report Years Considered
Figure 9. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions: 2020 VS 2027
Figure 12. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2022-2027)
Figure 13. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players in 2020
Figure 14. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue in 2020
Figure 16. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Figure 17. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2022-2027)
Figure 18. North America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027)
Figure 20. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027)
Figure 21. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027)
Figure 22. United States Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027)
Figure 26. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027)
Figure 27. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027)
Figure 28. Germany Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2016-2027)
Figure 38. China Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027)
Figure 46. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027)
Figure 47. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027)
Figure 48. Mexico Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027)
Figure 54. Turkey Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. 4SC Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 58. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 59. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 60. CellCentric Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 61. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 62. Celgene Corporation Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 63. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 64. Epigentek Group Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 65. Eisai Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 66. EnVivo Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 67. Base Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 68. Oryzon Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---